Reverse blood flow-glucose metabolism mismatch indicates preserved oxygen metabolism in patients with revascularised myocardial infarction
- PMID: 23624765
- DOI: 10.1007/s00259-013-2423-x
Reverse blood flow-glucose metabolism mismatch indicates preserved oxygen metabolism in patients with revascularised myocardial infarction
Abstract
Purpose: Positron emission tomography (PET) with (18)F-fluorodeoxyglucose (FDG) has been reported to be unreliable for identifying viable myocardium in acute myocardial infarction (AMI), especially in areas with discordance in myocardial blood flow (MBF) and glucose metabolism. In myocardium with decreased FDG uptake but preserved MBF, referred to as exhibiting reverse mismatch, myocardial viability remains controversial and little is known about the metabolic state. The aims of this study were to clarify substrate use and to estimate myocardial viability in infarct areas exhibiting reverse mismatch.
Methods: Eighteen AMI patients with successful revascularisation were included in this study. Two weeks after onset, (11)C-acetate and (18)F-FDG PET were performed to evaluate regional oxygen consumption (k mono), MBF and glucose metabolism. Free fatty acid (FFA) metabolism was evaluated with (123)I-15-(p-iodophenyl)-3-(R, S)-methylpentadecanoic acid (BMIPP) single photon emission computed tomography (SPECT). To assess wall motion, movement in left ventricular endocardial surface was calculated using ECG-gated (99m)Tc-tetrofosmin SPECT.
Results: The %k mono values in reverse mismatch segments (52.6 ± 13.6%) were not significantly different from those in non-infarct segments (60.4 ± 12.8%, p = 0.071) and normal match segments (preserved MBF and FDG uptake) (58.6 ± 11.6%, p = 0.396), although regional wall motion was more severely impaired (3.06 ± 2.52 mm vs 6.78 ± 3.17 mm, p < 0.0001, and vs 5.30 ± 2.33 mm, p = 0.042, respectively). Compared to segments with reduced match (reduced MBF and FDG uptake), %k mono and %BMIPP uptake were significantly higher in reverse mismatch segments (52.6 ± 13.6% vs 37.4 ± 8.9%, p = 0.0002, and 58.8 ± 10.6% vs 40.2 ± 10.7%, p < 0.0001).
Conclusion: Reverse mismatch in reperfused AMI patients, high oxygen consumption and FFA metabolism were observed despite decreased glucose metabolism. We conclude that reverse mismatch indicated the myocardium with early restoration of MBF and aerobic FFA metabolism.
Similar articles
-
Impaired myocardial microcirculation in the flow-glucose metabolism mismatch regions in revascularized acute myocardial infarction.J Nucl Cardiol. 2017 Oct;24(5):1641-1650. doi: 10.1007/s12350-016-0526-z. Epub 2016 Jun 14. J Nucl Cardiol. 2017. PMID: 27301963
-
Comparative assessment of 18F-fluorodeoxyglucose PET and 99mTc-tetrofosmin SPECT for the prediction of functional recovery in patients with reperfused acute myocardial infarction.Eur J Nucl Med Mol Imaging. 2006 Aug;33(8):879-86. doi: 10.1007/s00259-006-0071-0. Epub 2006 Apr 4. Eur J Nucl Med Mol Imaging. 2006. PMID: 16586079 Clinical Trial.
-
Serial changes in glucose-loaded 18F-fluoro-2-deoxyglucose positron emission tomography, 99mTc-tetrofosmin and 123I-beta-methyl-p-iodophenyl-penta-decanoic acid myocardial single-photon emission computed tomography images in patients with anterior acute myocardial infarction.Circ J. 2013;77(1):137-45. doi: 10.1253/circj.cj-12-0011. Epub 2012 Oct 3. Circ J. 2013. PMID: 23037521 Clinical Trial.
-
Imaging of cardiac metabolism using radiolabelled glucose, fatty acids and acetate.Coron Artery Dis. 2001 Feb;12 Suppl 1:S12-8. Coron Artery Dis. 2001. PMID: 11286301 Review.
-
Assessment of tissue viability with fluorine-18-fluoro-2-deoxyglucose (FDG) and carbon-11-acetate PET imaging.Herz. 1994 Feb;19(1):42-50. Herz. 1994. PMID: 8150413 Review.
Cited by
-
Cardiac MR imaging: current status and future direction.Cardiovasc Diagn Ther. 2015 Aug;5(4):290-310. doi: 10.3978/j.issn.2223-3652.2015.06.07. Cardiovasc Diagn Ther. 2015. PMID: 26331113 Free PMC article. Review.
-
Status of F-18 fluorodeoxyglucose uptake in normal and hibernating myocardium after glucose and insulin loading.J Saudi Heart Assoc. 2018 Apr;30(2):75-85. doi: 10.1016/j.jsha.2017.07.001. Epub 2017 Jul 10. J Saudi Heart Assoc. 2018. PMID: 29910577 Free PMC article.
-
Impaired myocardial microcirculation in the flow-glucose metabolism mismatch regions in revascularized acute myocardial infarction.J Nucl Cardiol. 2017 Oct;24(5):1641-1650. doi: 10.1007/s12350-016-0526-z. Epub 2016 Jun 14. J Nucl Cardiol. 2017. PMID: 27301963
-
Clinical significance of quantitative assessment of glucose utilization in patients with ischemic cardiomyopathy.J Nucl Cardiol. 2020 Feb;27(1):269-279. doi: 10.1007/s12350-018-1395-4. Epub 2018 Aug 14. J Nucl Cardiol. 2020. PMID: 30109593
-
Imaging of myocardial fatty acid oxidation.Biochim Biophys Acta. 2016 Oct;1861(10):1535-43. doi: 10.1016/j.bbalip.2016.02.019. Epub 2016 Feb 27. Biochim Biophys Acta. 2016. PMID: 26923433 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical